<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Atricure Inc — News on 6ix</title>
<link>https://6ix.com/company/atricure-inc</link>
<description>Latest news and press releases for Atricure Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/atricure-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835497078dffbe2df0e4418.webp</url>
<title>Atricure Inc</title>
<link>https://6ix.com/company/atricure-inc</link>
</image>
<item>
<title>AtriCure to Announce First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-to-announce-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-to-announce-first-quarter-2026-financial-results</guid>
<pubDate>Tue, 14 Apr 2026 12:00:00 GMT</pubDate>
<description>MASON, Ohio, April 14, 2026--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026.</description>
</item>
<item>
<title>AtriCure to Participate in the Citizens Life Sciences Conference</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-to-participate-in-the-citizens-life-sciences-conference</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-to-participate-in-the-citizens-life-sciences-conference</guid>
<pubDate>Tue, 24 Feb 2026 05:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-reports-fourth-quarter-2025-210100378</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-reports-fourth-quarter-2025-210100378</guid>
<pubDate>Tue, 17 Feb 2026 21:01:00 GMT</pubDate>
<description>MASON, Ohio, February 17, 2026--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2025 and full year 2025 financial results.</description>
</item>
<item>
<title>AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-announce-fourth-quarter-and-full-year-2025-financial-results-2026-01-27</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-announce-fourth-quarter-and-full-year-2025-financial-results-2026-01-27</guid>
<pubDate>Tue, 27 Jan 2026 05:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-reports-preliminary-results-fourth-quarter-and-full-year-2025-provides</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-reports-preliminary-results-fourth-quarter-and-full-year-2025-provides</guid>
<pubDate>Mon, 12 Jan 2026 05:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-participate-jp-morgan-44th-annual-healthcare-conference-2025-12-17</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-participate-jp-morgan-44th-annual-healthcare-conference-2025-12-17</guid>
<pubDate>Wed, 17 Dec 2025 05:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Announces the First Patients Treated with Novel Dual Energy Platform</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-announces-first-patients-treated-novel-dual-energy-platform-2025-12-11</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-announces-first-patients-treated-novel-dual-energy-platform-2025-12-11</guid>
<pubDate>Thu, 11 Dec 2025 05:00:00 GMT</pubDate>
<description>New technology combines Pulsed Field Ablation (PFA) and Advanced Radiofrequency Ablation with AtriCure’s EnCompass® clamp to reduce treatment time for</description>
</item>
<item>
<title>AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-participate-piper-sandler-37th-annual-healthcare-conference-2025-11-18</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-participate-piper-sandler-37th-annual-healthcare-conference-2025-11-18</guid>
<pubDate>Tue, 18 Nov 2025 05:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-reports-third-quarter-2025-financial-results-raises-financial-outlook-2025</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-reports-third-quarter-2025-financial-results-raises-financial-outlook-2025</guid>
<pubDate>Wed, 29 Oct 2025 04:00:00 GMT</pubDate>
<description>Worldwide revenue of $134.3 million – an increase of 15.8% year over year (15.1% constant currency) Net loss of $0.3 million – an improvement of $7.6 million</description>
</item>
<item>
<title>AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-announces-first-patient-treated-boxx-noaf-clinical-trial-2025-10-28</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-announces-first-patient-treated-boxx-noaf-clinical-trial-2025-10-28</guid>
<pubDate>Tue, 28 Oct 2025 04:00:00 GMT</pubDate>
<description>Trial will evaluate the safety and effectiveness of the AtriCure Isolator® Synergy™ EnCompass® clamp and AtriClip® Left Atrial Appendage Exclusion System to</description>
</item>
<item>
<title>AtriCure to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-participate-upcoming-investor-conferences-2025-10-27</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-participate-upcoming-investor-conferences-2025-10-27</guid>
<pubDate>Mon, 27 Oct 2025 04:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure to Announce Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-announce-third-quarter-2025-financial-results-2025-10-08</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-announce-third-quarter-2025-financial-results-2025-10-08</guid>
<pubDate>Wed, 08 Oct 2025 04:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-announces-launch-cryoxttm-device-post-operative-pain-management-following</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-announces-launch-cryoxttm-device-post-operative-pain-management-following</guid>
<pubDate>Tue, 09 Sep 2025 04:00:00 GMT</pubDate>
<description>New device expands AtriCure’s market opportunity in post-operative pain management while addressing a significant unmet clinical need MASON, Ohio--(BUSINESS</description>
</item>
<item>
<title>AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-participate-2025-wells-fargo-healthcare-conference-2025-08-20</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-participate-2025-wells-fargo-healthcare-conference-2025-08-20</guid>
<pubDate>Wed, 20 Aug 2025 04:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-reports-second-quarter-2025-financial-results-raises-financial-outlook-2025</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-reports-second-quarter-2025-financial-results-raises-financial-outlook-2025</guid>
<pubDate>Tue, 29 Jul 2025 04:00:00 GMT</pubDate>
<description>Worldwide revenue of $136.1 million – an increase of 17.1% year over year (16.5% constant currency) Net loss of $6.2 million – an improvement of $1.8 million</description>
</item>
<item>
<title>AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-participate-canaccord-genuity-45th-annual-growth-conference-2025-07-28</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-participate-canaccord-genuity-45th-annual-growth-conference-2025-07-28</guid>
<pubDate>Mon, 28 Jul 2025 04:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-completes-enrollment-leaaps-clinical-trial-stroke-prevention-2025-07-15</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-completes-enrollment-leaaps-clinical-trial-stroke-prevention-2025-07-15</guid>
<pubDate>Tue, 15 Jul 2025 04:00:00 GMT</pubDate>
<description>Largest cardiac surgery device trial ever with 6,500 patients enrolled, this landmark trial evaluates the stroke reduction benefit with AtriClip devices for</description>
</item>
<item>
<title>AtriCure to Announce Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-announce-second-quarter-2025-financial-results-2025-07-08</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-announce-second-quarter-2025-financial-results-2025-07-08</guid>
<pubDate>Tue, 08 Jul 2025 04:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-participate-goldman-sachs-46th-annual-global-healthcare-conference-2025-05</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-participate-goldman-sachs-46th-annual-global-healthcare-conference-2025-05</guid>
<pubDate>Fri, 23 May 2025 04:00:00 GMT</pubDate>
<description>MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left</description>
</item>
<item>
<title>AtriCure Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/atricure-inc/news/atricure-reports-first-quarter-2025-financial-results-2025-04-29</link>
<guid isPermaLink="true">https://6ix.com/company/atricure-inc/news/atricure-reports-first-quarter-2025-financial-results-2025-04-29</guid>
<pubDate>Tue, 29 Apr 2025 04:00:00 GMT</pubDate>
<description>Worldwide revenue of $123.6 million – an increase of 13.6% year over year (14.1% constant currency) Net loss of $6.7 million – an improvement of $6.5 million</description>
</item>
</channel>
</rss>